Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study
- Author
- TAKEUCHI, J; KYO, T; ASOU, N; INO, T; OKAMOTO, T; USUI, N; NISHIMURA, M; SHINAGAWA, K; FUKUSHIMA, T; TAGUCHI, H; MORII, T; MIZUTA, S; NAITO, K; AKIYAMA, H; NAKAMURA, Y; OHSHIMA, T; OHNO, R; SAO, H; TAKAHASHI, M; MIYAWAKI, S; KURIYAMA, K; OHTAKE, S; YAGASAKI, F; MURAKAMI, H
- Source
Leukemia. 2002, Vol 16, Num 7, pp 1259-1266, 8 p ; ref : 28 ref
- CODEN
- LEUKED
- ISSN
- 0887-6924
- Scientific domain
- Medical oncology; Hematology
- Publisher
- Nature Publishing, London
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Adulte Agent alkylant Aigu Alcaloïde Anthracyclines Antibiotique Anticancéreux Antifolate Antimitotique Antimétabolite Asparaginase Association médicamenteuse Chimiothérapie Corticostéroïde Cyclophosphamide DNA topoisomerase (ATP-hydrolysing) Doxorubicine Glucocorticoïde Greffe Homogreffe Inhibiteur enzyme Leucémie lymphoblastique Mercaptopurine Moelle osseuse Moutarde à l'azote Méthotrexate Oxazaphosphinane dérivé Prednisolone Pronostic Purine nucléoside Traitement associé Traitement entretien Traitement induction Vincristine Traitement consolidation Enzyme Homme Hydrolases Hémopathie maligne Isomerases Lymphoprolifératif syndrome
- Keyword (en)
- Adult Alkylating agent Acute Alkaloid Anthracyclins Antibiotic Antineoplastic agent Antifolate Antimitotic Antimetabolic Asparaginase Drug combination Chemotherapy Corticosteroid Cyclophosphamide DNA topoisomerase (ATP-hydrolysing) Doxorubicin Glucocorticoid Graft Homograft Enzyme inhibitor Acute lymphocytic leukemia Mercaptopurine Bone marrow Nitrogen mustard Methotrexate Oxazaphosphinane derivatives Prednisolone Prognosis Purine nucleoside Combined treatment Maintenance treatment Induction treatment Vincristine Enzyme Human Hydrolases Malignant hemopathy Isomerases Lymphoproliferative syndrome
- Keyword (es)
- Adulto Agente alquilante Agudo Alcaloide Antraciclinas Antibiótico Anticanceroso Antifolato Antimitótico Antimetabólito Asparaginase Asociación medicamentosa Quimioterapia Corticoesteroide Ciclofosfamida DNA topoisomerase (ATP-hydrolysing) Doxorubicina Glucocorticoide Injerto Homoinjerto Inhibidor enzima Leucemia linfoblástica Mercaptopurina Médula ósea Mostaza al nitrógeno Metotrexato Oxazafosfinano derivado Prednisolona Pronóstico Purina nucleósido Tratamiento asociado Tratamiento sostén Tratamiento inductivo Vincristina Enzima Hombre Hydrolases Hemopatía maligna Isomerases Linfoproliferativo síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R04 Combined treatments (chemotherapy of immunotherapy associated with an other treatment)
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13797645
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/sj.leu.2402526 
https://dx.doi.org/10.1038/sj.leu.2402526
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.leu.2402526\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"16\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1259\";s:8:\"\u0000*\u0000epage\";s:4:\"1266\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"TAKEUCHI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:6:\"KYO, T\";i:1;s:7:\"ASOU, N\";i:2;s:6:\"INO, T\";i:3;s:10:\"OKAMOTO, T\";i:4;s:7:\"USUI, N\";i:5;s:12:\"NISHIMURA, M\";i:6;s:12:\"SHINAGAWA, K\";i:7;s:12:\"FUKUSHIMA, T\";i:8;s:10:\"TAGUCHI, H\";i:9;s:8:\"MORII, T\";i:10;s:9:\"MIZUTA, S\";i:11;s:8:\"NAITO, K\";i:12;s:10:\"AKIYAMA, H\";i:13;s:11:\"NAKAMURA, Y\";i:14;s:10:\"OHSHIMA, T\";i:15;s:7:\"OHNO, R\";i:16;s:6:\"SAO, H\";i:17;s:12:\"TAKAHASHI, M\";i:18;s:11:\"MIYAWAKI, S\";i:19;s:11:\"KURIYAMA, K\";i:20;s:9:\"OHTAKE, S\";i:21;s:11:\"YAGASAKI, F\";i:22;s:11:\"MURAKAMI, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.leu.2402526\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"16\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1259\";s:8:\"\u0000*\u0000epage\";s:4:\"1266\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"TAKEUCHI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:6:\"KYO, T\";i:1;s:7:\"ASOU, N\";i:2;s:6:\"INO, T\";i:3;s:10:\"OKAMOTO, T\";i:4;s:7:\"USUI, N\";i:5;s:12:\"NISHIMURA, M\";i:6;s:12:\"SHINAGAWA, K\";i:7;s:12:\"FUKUSHIMA, T\";i:8;s:10:\"TAGUCHI, H\";i:9;s:8:\"MORII, T\";i:10;s:9:\"MIZUTA, S\";i:11;s:8:\"NAITO, K\";i:12;s:10:\"AKIYAMA, H\";i:13;s:11:\"NAKAMURA, Y\";i:14;s:10:\"OHSHIMA, T\";i:15;s:7:\"OHNO, R\";i:16;s:6:\"SAO, H\";i:17;s:12:\"TAKAHASHI, M\";i:18;s:11:\"MIYAWAKI, S\";i:19;s:11:\"KURIYAMA, K\";i:20;s:9:\"OHTAKE, S\";i:21;s:11:\"YAGASAKI, F\";i:22;s:11:\"MURAKAMI, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.leu.2402526\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.leu.2402526\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"16\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1259\";s:8:\"\u0000*\u0000epage\";s:4:\"1266\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"TAKEUCHI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:6:\"KYO, T\";i:1;s:7:\"ASOU, N\";i:2;s:6:\"INO, T\";i:3;s:10:\"OKAMOTO, T\";i:4;s:7:\"USUI, N\";i:5;s:12:\"NISHIMURA, M\";i:6;s:12:\"SHINAGAWA, K\";i:7;s:12:\"FUKUSHIMA, T\";i:8;s:10:\"TAGUCHI, H\";i:9;s:8:\"MORII, T\";i:10;s:9:\"MIZUTA, S\";i:11;s:8:\"NAITO, K\";i:12;s:10:\"AKIYAMA, H\";i:13;s:11:\"NAKAMURA, Y\";i:14;s:10:\"OHSHIMA, T\";i:15;s:7:\"OHNO, R\";i:16;s:6:\"SAO, H\";i:17;s:12:\"TAKAHASHI, M\";i:18;s:11:\"MIYAWAKI, S\";i:19;s:11:\"KURIYAMA, K\";i:20;s:9:\"OHTAKE, S\";i:21;s:11:\"YAGASAKI, F\";i:22;s:11:\"MURAKAMI, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.leu.2402526\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"16\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1259\";s:8:\"\u0000*\u0000epage\";s:4:\"1266\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"TAKEUCHI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:6:\"KYO, T\";i:1;s:7:\"ASOU, N\";i:2;s:6:\"INO, T\";i:3;s:10:\"OKAMOTO, T\";i:4;s:7:\"USUI, N\";i:5;s:12:\"NISHIMURA, M\";i:6;s:12:\"SHINAGAWA, K\";i:7;s:12:\"FUKUSHIMA, T\";i:8;s:10:\"TAGUCHI, H\";i:9;s:8:\"MORII, T\";i:10;s:9:\"MIZUTA, S\";i:11;s:8:\"NAITO, K\";i:12;s:10:\"AKIYAMA, H\";i:13;s:11:\"NAKAMURA, Y\";i:14;s:10:\"OHSHIMA, T\";i:15;s:7:\"OHNO, R\";i:16;s:6:\"SAO, H\";i:17;s:12:\"TAKAHASHI, M\";i:18;s:11:\"MIYAWAKI, S\";i:19;s:11:\"KURIYAMA, K\";i:20;s:9:\"OHTAKE, S\";i:21;s:11:\"YAGASAKI, F\";i:22;s:11:\"MURAKAMI, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.leu.2402526\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"16\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1259\";s:8:\"\u0000*\u0000epage\";s:4:\"1266\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"TAKEUCHI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:23:{i:0;s:6:\"KYO, T\";i:1;s:7:\"ASOU, N\";i:2;s:6:\"INO, T\";i:3;s:10:\"OKAMOTO, T\";i:4;s:7:\"USUI, N\";i:5;s:12:\"NISHIMURA, M\";i:6;s:12:\"SHINAGAWA, K\";i:7;s:12:\"FUKUSHIMA, T\";i:8;s:10:\"TAGUCHI, H\";i:9;s:8:\"MORII, T\";i:10;s:9:\"MIZUTA, S\";i:11;s:8:\"NAITO, K\";i:12;s:10:\"AKIYAMA, H\";i:13;s:11:\"NAKAMURA, Y\";i:14;s:10:\"OHSHIMA, T\";i:15;s:7:\"OHNO, R\";i:16;s:6:\"SAO, H\";i:17;s:12:\"TAKAHASHI, M\";i:18;s:11:\"MIYAWAKI, S\";i:19;s:11:\"KURIYAMA, K\";i:20;s:9:\"OHTAKE, S\";i:21;s:11:\"YAGASAKI, F\";i:22;s:11:\"MURAKAMI, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:17:\"Nature Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
